Sub-component for Institution # 16-01848 Core 1 - Administrative
机构的子组件
基本信息
- 批准号:9978751
- 负责人:
- 金额:$ 9.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AdherenceAdvisory CommitteesAwardBiologicalBrain NeoplasmsCancer CenterClinicalCollaborationsCommunicationCommunitiesDataDoctor of MedicineDoctor of PhilosophyEnsureFacultyFoundationsGlioblastomaGrantIACUCInstitutesInstitutionInternationalJournalsLeadershipManuscriptsMonitorNatureOutputPatientsPeriodicityPreparationProfessional OrganizationsPublicationsRadiology SpecialtyRecording of previous eventsRecordsReportingResearchResearch PersonnelResource SharingResourcesRoleScientistSiteTeleconferencesTexasTherapeuticTherapeutic EffectTimeTimeLineTranslational ResearchTravelUniversitiesVirginiaVisitWorkaustindata sharingexperiencemeetingsmembermultidisciplinaryprogramsquality assuranceskillsworking group
项目摘要
CORE 1
Summary
The primary objective of the Administrative Core, Core 1, is to provide overall administrative support to the
program. This administrative support will include communication with the institutional administration,
maintaining and distributing records regarding the fiscal management of the grant, preparing annual program
reports, and coordinating the meetings of the advisory committees and interfacing with investigators at other
institutions involved. In addition, the Administrative Core will maintain records of such things as Institutional
Animal Care and Use Committee approvals, and other institutional compliance items. These activities will be
under the direction of Dr. Waldemar Debinski and he will be supported by Dr. King Li and advised by the
project and core investigators concerning all aspects of progress on the project and administrative issues. The
administrative team is made up of senior investigators serving as project and core leaders or co-investigators
and an administrative secretary and program manager with extensive experience in coordinating and
managing the activities of larger groups.
The following specific aims and objectives are proposed: 1) To promote efficient use of the PPG's resources,
including adherence of cores to standards to ensure high quality data output and prioritizing access; 2) to
promote the exchange of scientific ideas and data within not only the PO1 Working Group, made up of the
Project Leaders, the Directors of the Cores, and the Co-investigators participating in this PPG, but also with the
investigators who are part of the program and located at other institutions, and with the larger scientific
community; 3) to provide internal and external review of the progress made by the PPG.
核心1
概括
行政核心(核心 1)的主要目标是为
程序。这种行政支持将包括与机构管理部门的沟通,
维护和分发有关赠款财务管理的记录,制定年度计划
报告、协调咨询委员会会议以及与其他机构的调查人员进行交流
涉及机构。此外,行政核心将保存机构等事项的记录
动物护理和使用委员会的批准,以及其他机构合规项目。这些活动将
在 Waldemar Debinski 博士的指导下,他将得到 King Li 博士的支持并得到
项目和核心调查员关注项目进展的各个方面和行政问题。这
管理团队由担任项目的高级研究员和核心负责人或共同研究员组成
以及一名在协调和协调方面具有丰富经验的行政秘书和项目经理
管理较大群体的活动。
建议提出以下具体目的和目标: 1) 促进 PPG 资源的有效利用,
包括遵守核心标准,以确保高质量的数据输出和优先访问; 2)到
不仅在由 PO1 组成的 PO1 工作组内促进科学思想和数据的交流
参与本 PPG 的项目负责人、核心主任和联合研究者,但也包括
属于该计划一部分并位于其他机构的研究人员,并且具有更大的科学
社区; 3) 对 PPG 取得的进展进行内部和外部审查。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Waldemar Debinski其他文献
Waldemar Debinski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Waldemar Debinski', 18)}}的其他基金
Combinatorial Immunotherapy using a Multivalent Drug Conjugate for GBM Treatment
使用多价药物偶联物进行 GBM 治疗的组合免疫疗法
- 批准号:
10560392 - 财政年份:2022
- 资助金额:
$ 9.1万 - 项目类别:
Sub-component for Institution # 16-01848 Novel moleculary targeted therapy of GBM
机构的子组件
- 批准号:
10493966 - 财政年份:2017
- 资助金额:
$ 9.1万 - 项目类别:
Rapid Electrical Impedance Spectroscopy for Detection of High-Frequency Irreversible Electroporation Ablation Growth in a Rodent Glioma Model
快速电阻抗光谱法检测啮齿动物神经胶质瘤模型中高频不可逆电穿孔消融生长
- 批准号:
10310562 - 财政年份:2017
- 资助金额:
$ 9.1万 - 项目类别:
Maximizing Local Access to Therapeutic Deliveries in Glioblastoma
最大限度地提高胶质母细胞瘤的本地治疗交付机会
- 批准号:
10220880 - 财政年份:2017
- 资助金额:
$ 9.1万 - 项目类别:
Maximizing Local Access to Therapeutic Deliveries in Glioblastoma
最大限度地提高胶质母细胞瘤的本地治疗交付机会
- 批准号:
9978729 - 财政年份:2017
- 资助金额:
$ 9.1万 - 项目类别:
Sub-component for Institution # 16-01848 Core 1 - Administrative
机构的子组件
- 批准号:
10220885 - 财政年份:2017
- 资助金额:
$ 9.1万 - 项目类别:
Sub-component for Institution # 16-01848 Novel moleculary targeted therapy of GBM
机构的子组件
- 批准号:
10220881 - 财政年份:2017
- 资助金额:
$ 9.1万 - 项目类别:
Molecular Combinatorial Therapy of Glioblastoma Multiforme
多形性胶质母细胞瘤的分子组合治疗
- 批准号:
8010645 - 财政年份:2010
- 资助金额:
$ 9.1万 - 项目类别:
相似海外基金
Social Vulnerability, Sleep, and Early Hypertension Risk in Younger Adults
年轻人的社会脆弱性、睡眠和早期高血压风险
- 批准号:
10643145 - 财政年份:2023
- 资助金额:
$ 9.1万 - 项目类别:
I-TrainED: Innovative Training and Education in Diabetes
I-TrainED:糖尿病创新培训和教育
- 批准号:
10795135 - 财政年份:2023
- 资助金额:
$ 9.1万 - 项目类别:
Midcareer Development Award in Neuroaging and Geriatric Pharmacoepidemiology Research
神经衰老和老年药物流行病学研究职业中期发展奖
- 批准号:
10351611 - 财政年份:2022
- 资助金额:
$ 9.1万 - 项目类别: